Breast Cancer Drug T-DM1 Shows Promise in Trial
Breast Cancer Drug T-DM1 Shows Promise in Trial
K Wachter
20110913
2011 Oct 13
Elsevier Global Medical News
Find more items about these cancer types:
Breast Cancer Drug T-DM1 Shows Promise in Trial
(00:03:06) Elsevier Global Medical News, 2011 Oct 13, K Wachter
Dr. Hope Rugo, Associate Editor of the Oncology Report, discusses the first comparative data on TDM-1 in metastatic breast cancer.
/Images/Hope_Rugo_tcm8-271536.jpg
Related Links:
News Article: Trastuzumab-Based T-DM1 Delays Breast Cancer Progression »
Journal Scans: Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)–Positive Breast Cancer After Prior HER2-Directed Therapy »
News Article: Trastuzumab-DM1 Shows Great Promise in Advanced Breast Cancer »
Copyright © 2011 International Medical News Group
Subscribe Now »
Subscribe Now »
